PODD - インスレット (Insulet Corporation) インスレット

 PODDのチャート


 PODDの企業情報

symbol PODD
会社名 Insulet Corp (インスレット)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 インシュレット(Insulet Corporation)はインスリン依存型糖尿病患者用のインスリン注入システムであるOmniPodインスリン管理システム(OmniPodシステム)の開発・製造・販売に従事する会社である。OmniPodシステムは一度に約3日間身体に装着される使い捨てのチューブレスOmniPodデバイス、並びに同社のハンドヘルド・無線パーソナル糖尿病マネージャー(PDM)製品を搭載する。OmniPodシステムはポンプ、チュービングの必要性を排除し、自動カニューレ挿入を提供し、無線で通信し、血糖計を統合する2つの装置を備える。OmniPodシステムは従来のポンプで必要とされる外部配管の必要性を排除する2つの部分からなるデザイン、OmniPodデバイス(Pod)およびPDMである。Podは患者がインスリンを満たし、身体に直接着用する自己粘着性装置である。   インスレットは、米国の医療装置メ―カ―。インスリン依存性糖尿病のために、インスリン注入システム「オムニポッド」を開発、製造、販売する。チュ―ブのない「オムニポッド」は約3日間、身体に装着し、「パ―ソナル糖尿病管理」という携帯の制御装置と無線で交信する。このシステムは、自動カニュ―レ挿入機能を備え、血糖測定器を内蔵している。   Insulet Corp. is a medical device company. The firm engages in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
本社所在地 600 Technology Park Drive Suite 200 Billerica MA 01821 USA
代表者氏名 Patrick J. Sullivan Patrick J. Sullivan
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 978-600-7000
設立年月日 36708
市場名 NASDAQ National Market System
ipoyear 2007年
従業員数 857人
url www.insulet.com
nasdaq_url https://www.nasdaq.com/symbol/podd
adr_tso
EBITDA EBITDA(百万ドル) 19.92800
終値(lastsale) 92.93
時価総額(marketcap) 5482592325.16
時価総額 時価総額(百万ドル) 5202.946
売上高 売上高(百万ドル) 500.13900
企業価値(EV) 企業価値(EV)(百万ドル) 5480.273
当期純利益 当期純利益(百万ドル) -17.04700
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Insulet Corporation revenues increased 17% to $247.8M. Net loss decreased 53% to $8.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other income (expense) net increase from $922K to $3.4M (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.31 to -$0.14.

 PODDのテクニカル分析


 PODDのニュース

   Insulet Reports Second Quarter 2020 Revenue Increase of 28% Year-Over-Year  2020/08/06 20:01:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months ended June 30, 2020. Second Quarter Financial Highlights: Second quarter 2020 revenue of $226.3 million, up 27.8%, or 28.8% in constant currency1, compared to $177.1 million in the prior year, exceeds guidance of 19% to 23% on a constan
   Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020  2020/06/29 10:00:00 Business Wire
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Managemen
   Insulet Installs Solar Panels at Its Global Headquarters and U.S. Manufacturing Facility to Help Reduce Its Carbon Footprint  2020/06/24 10:00:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced its corporate headquarters and manufacturing facility in Acton, MA, will be powered by solar-based, renewable energy beginning this week. Insulet covered its 58,000 square-foot manufacturing facility with approximately 2,800 solar panels, each measuring 5.5 feet long by 3.3 feet wide. Duri
   Insulet Presents Omnipod Virtual Care Experience and Pre-Pivotal Study Results at the American Diabetes Association 80th Scientific Sessions  2020/06/11 10:00:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced its robust schedule of events for the American Diabetes Association (ADA) 80th Scientific Sessions: A Virtual Experience, June 12 – 16, 2020. Omnipod® 5 Automated Glucose Control System, Powered by Horizon™ (Omnipod 5), formerly known as the Omnipod Horizon System, is the first tubeless sm
   Insulet Resumes Pivotal Study of its Next-Generation Product - Omnipod, Powered by Horizon™  2020/06/05 10:00:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced it has resumed its pivotal study of Omnipod, Powered by Horizon™, the Company’s personal smart-phone controlled automated insulin delivery system. The Company paused the study, which was approximately halfway through completion, in March. “We are thrilled to continue our trial,” said Dr. Tra
   Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020  2020/06/29 10:00:00 Business Wire
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Managemen
   Insulet Installs Solar Panels at Its Global Headquarters and U.S. Manufacturing Facility to Help Reduce Its Carbon Footprint  2020/06/24 10:00:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced its corporate headquarters and manufacturing facility in Acton, MA, will be powered by solar-based, renewable energy beginning this week. Insulet covered its 58,000 square-foot manufacturing facility with approximately 2,800 solar panels, each measuring 5.5 feet long by 3.3 feet wide. Duri
   Insulet Presents Omnipod Virtual Care Experience and Pre-Pivotal Study Results at the American Diabetes Association 80th Scientific Sessions  2020/06/11 10:00:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced its robust schedule of events for the American Diabetes Association (ADA) 80th Scientific Sessions: A Virtual Experience, June 12 – 16, 2020. Omnipod® 5 Automated Glucose Control System, Powered by Horizon™ (Omnipod 5), formerly known as the Omnipod Horizon System, is the first tubeless sm
   Insulet Resumes Pivotal Study of its Next-Generation Product - Omnipod, Powered by Horizon™  2020/06/05 10:00:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced it has resumed its pivotal study of Omnipod, Powered by Horizon™, the Company’s personal smart-phone controlled automated insulin delivery system. The Company paused the study, which was approximately halfway through completion, in March. “We are thrilled to continue our trial,” said Dr. Tra
   Ypsomed verdient 2019/20 deutlich weniger - letztlich höher  2020/05/27 15:56:37 Finanzen CH
Grund dafür ist die Trennung von der US-Firma Insulet, für die Ypsomed während Jahren die Insulinpumpe "Omnipod" verkauft hat. Verzögerungen bei der Marktlancierung der selbst entwickelten Insulinpumpe dämpften die Geschäftsentwicklung zusätzlich. Der Umsatz…
   Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020  2020/06/29 10:00:00 Business Wire
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Managemen
   Insulet Installs Solar Panels at Its Global Headquarters and U.S. Manufacturing Facility to Help Reduce Its Carbon Footprint  2020/06/24 10:00:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced its corporate headquarters and manufacturing facility in Acton, MA, will be powered by solar-based, renewable energy beginning this week. Insulet covered its 58,000 square-foot manufacturing facility with approximately 2,800 solar panels, each measuring 5.5 feet long by 3.3 feet wide. Duri
   Insulet Presents Omnipod Virtual Care Experience and Pre-Pivotal Study Results at the American Diabetes Association 80th Scientific Sessions  2020/06/11 10:00:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced its robust schedule of events for the American Diabetes Association (ADA) 80th Scientific Sessions: A Virtual Experience, June 12 – 16, 2020. Omnipod® 5 Automated Glucose Control System, Powered by Horizon™ (Omnipod 5), formerly known as the Omnipod Horizon System, is the first tubeless sm
   Insulet Resumes Pivotal Study of its Next-Generation Product - Omnipod, Powered by Horizon™  2020/06/05 10:00:00 Business Wire
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced it has resumed its pivotal study of Omnipod, Powered by Horizon™, the Company’s personal smart-phone controlled automated insulin delivery system. The Company paused the study, which was approximately halfway through completion, in March. “We are thrilled to continue our trial,” said Dr. Tra
   Ypsomed verdient 2019/20 deutlich weniger - letztlich höher  2020/05/27 15:56:37 Finanzen CH
Grund dafür ist die Trennung von der US-Firma Insulet, für die Ypsomed während Jahren die Insulinpumpe "Omnipod" verkauft hat. Verzögerungen bei der Marktlancierung der selbst entwickelten Insulinpumpe dämpften die Geschäftsentwicklung zusätzlich. Der Umsatz…

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 インスレット PODD Insulet Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)